Evaluating the Relationship between Ceramides and Depressive Symptoms in Coronary Artery Disease Patients
Year: 2016
Type: dissertation
Study design: Observational Study
Abstract: Depression is highly prevalent in individuals with coronary artery disease (CAD), and increases risk of mortality. Ceramides, a family of sphingolipid species, have been implicated in the pathophysiology of both CAD and depression due to their pro-inflammatory and pro-apoptotic characteristics. This study assessed the relationship between ceramides and depression in a CAD population. Linear regression models were used to assess the association between plasma ceramide concentrations and depressive symptoms, as measured by the Center for Epidemiological Studies Depression Scale (CESD). High performance liquid chromatography coupled electrospray ionization tandem mass spectrometry was used to measure ceramide species. Higher plasma concentrations of the ceramide species C16:0 (β=0.195, p=0.039) and C22:1 (β=0.199, p=0.039) were significantly associated with greater depressive symptoms. Plasma concentrations of C18:0 (β =0.108, p=0.257) and C20:0 (β=0.167, p=0.078) were not significantly associated with depressive symptoms. Findings suggest a potential role of specific ceramides in the pathophysiology of depression in CAD.
Source: TSpace (University of Toronto)
Author: Dinoff, Adam
Institution: University of Toronto
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6991101591
